- Action
- The recalling firm issued letters on and dated 4/22/2024 via traceable means informing the consignee of the affected product details, safety issue, and actions to be taken by the customer/user. The consignee was informed they can continue to use the Prucka 3 Amplifiers with the CardioLab/ComboLab systems with the following conditions:
(1) Ensure additional devices are immediately available to monitor surface and intracardiac ECG waveforms in order to complete the study (e.g. patient monitor, 3D mapping system, etc.) until the device is corrected;
(2) In the event the Prucka 3 Amplifier malfunction occurs during the case with the loss of ECG waveforms, use an alternate device;
(3) Ensure the hospital staff are familiar with utilizing the Direct Stimulator Connections on the CIM Block(s). This allows pacing from the stimulator if the amplifier is not functioning properly.
The consignee is to ensure all potential users in the facility are made aware of this safety notification and the recommended actions.
An acknowledgment form was enclosed for completion and return no later than 30 days from receipt of the letter.
GE HealthCare will correct all affected devices and a representative will contact the consignee to arrange for the correction.
- Initiated
- 2024-04-22
- Root cause
- Process control
- Distribution
- Worldwide - US Nationwide distribution in the states of AK, AZ, CA, CO, FL, GA, IL, KY, MA, ME, MN, MO, NC, NJ, NY, OH, OR, PA, TN, TX, and WA. The countries of Belgium, Canada, Czech Republic, France, Germany, Ireland, Israel, Italy, Japan, Republic of Korea, and Singapore.
- Recall number
- Z-2258-2024
- Recall status
- Open, Classified
- CDRH record ID
- 208103
- FDA classified
- 2024-07-03
- Recall event number
- 94717